Response to imatinib in patients who relapse after allogeneic stem cell transplantation for chronic myeloid leukemia

被引：0
|
作者：
A Bacigalupo
机构：
[1] Osp San Martino,Department of Hematology
来源：
Leukemia | 2003年 / 17卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1722 / 1722
相关论文
共 50 条
  • [1] Response to imatinib in patients who relapse after allogeneic stem cell transplantation for chronic myeloid leukemia
    E Olavarria
    O G Ottmann
    M Deininger
    R E Clark
    G Bandini
    J Byrne
    J Lipton
    A Vitek
    M Michallet
    W Siegert
    A Ullmann
    B Wassmann
    D Niederwieser
    T Fischer
    Leukemia, 2003, 17 : 1707 - 1712
  • [2] Response to imatinib in patients who relapse after allogeneic stem cell transplantation for chronic myeloid leukemia
    Olavarria, E
    Ottmann, OG
    Deininger, M
    Clark, RE
    Bandini, G
    Byrne, J
    Lipton, J
    Vitek, A
    Michallet, M
    Siegert, W
    Ullmann, A
    Wassmann, B
    Niederwieser, D
    Fischer, T
    LEUKEMIA, 2003, 17 (09) : 1707 - 1712
  • [3] Imatinib therapy for chronic myeloid leukemia patients who relapse after allogeneic stem cell transplantation: A molecular analysis
    Palandri, F
    Martinelli, G
    Amabile, M
    Bonifazi, F
    Bandini, G
    Benedetti, F
    Usala, E
    Angelucci, E
    Tiribelli, M
    Fanin, R
    Sorio, M
    Arpinati, M
    Testoni, N
    Falcioni, S
    Giannini, MB
    Poerio, A
    Soverini, S
    Pane, F
    Rosti, G
    Tura, S
    Baccarani, M
    BLOOD, 2004, 104 (11) : 247B - 247B
  • [4] Imatinib therapy for chronic myeloid leukemia patients who relapse after allogeneic stem cell transplantation: a molecular analysis
    Palandri, F.
    Amabile, M.
    Rosti, G.
    Bandini, G.
    Benedetti, F.
    Usala, E.
    Angelucci, E.
    Tiribelli, M.
    Fanin, R.
    Martinelli, G.
    Baccarani, M.
    BONE MARROW TRANSPLANTATION, 2007, 39 (03) : 189 - 191
  • [5] Imatinib therapy for chronic myeloid leukemia patients who relapse after allogeneic stem cell transplantation: a molecular analysis
    F Palandri
    M Amabile
    G Rosti
    G Bandini
    F Benedetti
    E Usala
    E Angelucci
    M Tiribelli
    R Fanin
    G Martinelli
    M Baccarani
    Bone Marrow Transplantation, 2007, 39 : 189 - 191
  • [6] Imatinib therapy for chronic myeloid leukaemia patients who relapse after allogeneic stem cell transplantation: a molecular analysis
    Martinelli, G
    Palandri, F
    Amabile, M
    Bonifazi, F
    Bandini, G
    Benedetti, F
    Usala, E
    Angelucci, E
    Tiribelli, M
    Fanin, R
    Sorio, M
    Arpinati, M
    Testoni, N
    Falcioni, S
    Giannini, M
    Poerio, A
    Soverini, S
    Pane, F
    Rosti, G
    Baccarani, M
    BONE MARROW TRANSPLANTATION, 2005, 35 : S236 - S236
  • [7] Imatinib mesylate (STI571) in the treatment of relapse of chronic myeloid leukemia after allogeneic stem cell transplantation
    Olavarria, E
    Craddock, C
    Dazzi, F
    Marin, D
    Marktel, S
    Apperley, JF
    Goldman, JM
    BLOOD, 2002, 99 (10) : 3861 - 3862
  • [8] Imatinib mesylate in the treatment of relapse of chronic myeloid leukemia after allogeneic stem sell transplantation.
    Zhu, KG
    Zhang, T
    Chen, J
    Zhong, J
    BLOOD, 2005, 106 (11) : 291B - 291B
  • [9] Imatinib combined with allogeneic stem cell transplantation for chronic myeloid leukemia
    Luo, Yi
    Huang, He
    Tan, Yamin
    Han, Xiaoyan
    Zhu, Xiaoli
    Lai, Xiaoyu
    Zhen, Cai
    Lin, Maofang
    BLOOD, 2007, 110 (11) : 871A - 871A
  • [10] Imatinib preceding allogeneic stem cell transplantation in chronic myeloid leukemia
    Perz, Jolanta B.
    Khorashad, Jamshid S.
    Marin, David
    Apperley, Jane F.
    Olavarria, Eduardo
    HAEMATOLOGICA, 2006, 91 (08) : 1145 - 1146
12345